Search

Author/Creator Lasseter, Kenneth C.

2. Effect of Mild and Moderate Hepatic Impairment (Defined by Child–Pugh Classification and National Cancer Institute Organ Dysfunction Working Group Criteria) on Pexidartinib Pharmacokinetics. (31st March 2022)

Authors:
Zahir, Hamim; Greenberg, Jonathan; Hsu, Ching; Marbury, Thomas C.; Lasseter, Kenneth C.; Xu, Li‐An; Tap, William D.; Healey, John H.; Stacchiotti, Silvia; LaCreta, Frank
Journal:
Journal of clinical pharmacology
Issue:
Volume 62:Number 8(2022)
Page Start:
992
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. A Microdose Cocktail to Evaluate Drug Interactions in Patients with Renal Impairment. Issue 2 (26th October 2020)

Authors:
Tatosian, Daniel A.; Yee, Ka Lai; Zhang, Zufei; Mostoller, Kate; Paul, Erina; Sutradhar, Santosh; Larson, Patrick; Chhibber, Aparna; Wen, Jianzhong; Wang, Ya‐Juan; Lassman, Michael; Latham, Andrew H.; Pang, Jianmei; Crumley, Tami; Gillespie, Anne; Marricco, Nadia Cardillo; Marenco, Ted; Murphy, M...
Journal:
Clinical pharmacology & therapeutics
Issue:
Volume 109:Issue 2(2021)
Page Start:
403
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. A Microdose Cocktail to Evaluate Drug Interactions in Patients with Renal Impairment. Issue 2 (26th October 2020)

Authors:
Tatosian, Daniel A.; Yee, Ka Lai; Zhang, Zufei; Mostoller, Kate; Paul, Erina; Sutradhar, Santosh; Larson, Patrick; Chhibber, Aparna; Wen, Jianzhong; Wang, Ya‐Juan; Lassman, Michael; Latham, Andrew H.; Pang, Jianmei; Crumley, Tami; Gillespie, Anne; Marricco, Nadia Cardillo; Marenco, Ted; Murphy, M...
Journal:
Clinical pharmacology & therapeutics
Issue:
Volume 109:Issue 2(2021)
Page Start:
403
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Pharmacokinetic Interactions Between Isavuconazole and the Drug Transporter Substrates Atorvastatin, Digoxin, Metformin, and Methotrexate in Healthy Subjects. Issue 1 (15th July 2016)

Authors:
Yamazaki, Takao; Desai, Amit; Goldwater, Ronald; Han, David; Lasseter, Kenneth C.; Howieson, Corrie; Akhtar, Shahzad; Kowalski, Donna; Lademacher, Christopher; Rammelsberg, Diane; Townsend, Robert
Journal:
Clinical pharmacology in drug development
Issue:
Volume 6:Issue 1(2017)
Page Start:
66
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Influence of renal and hepatic impairment on the pharmacokinetics of anacetrapib. (6th June 2014)

Authors:
Lauring, Brett; Li, Xiujiang (Susie); Liu, Yang; Corr, Christy; Lazarus, Nicole; Cote, Josee; Larson, Patrick; Levonas, Amy O. Johnson; Lasseter, Kenneth C.; Preston, Richard A.; Smith, William B.; Lai, Eseng; Wagner, John A.
Journal:
Journal of clinical pharmacology
Issue:
Volume 54:Number 11(2014:Nov.)
Page Start:
1247
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Odanacatib, a selective cathepsin K inhibitor to treat osteoporosis: safety, tolerability, pharmacokinetics and pharmacodynamics – results from single oral dose studies in healthy volunteers. (8th April 2013)

Authors:
Stoch, S. Aubrey; Zajic, Stefan; Stone, Julie A.; Miller, Deborah L.; van, Lucas; Lasseter, Kenneth C.; Pramanik, Barnali; Cilissen, Caroline; Liu, Qi; Liu, Lida; Scott, Boyd B.; Panebianco, Deborah; Ding, Yu; Gottesdiener, Keith; Wagner, John A.
Journal:
British journal of clinical pharmacology
Issue:
Volume 75:Number 5(2013:May)
Page Start:
1240
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗